Evaluating the investigational drug landscape for ESR1 -mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer
Marie Kroemer, Morgane Lopez, Laura Mansi, Elsa Curtit
0 citationsExpert Opinion on Investigational Drugs
Marie Kroemer
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
70Publications signalées
619Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
CAR-T cell therapy researchCancer Immunotherapy and BiomarkersRenal and related cancersImmunotherapy and Immune ResponsesSARS-CoV-2 and COVID-19 Research
Publications récentes
Figure S1 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S2 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S7 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Data from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S5 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S10 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S4 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Supplementary Table S2 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S6 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Supplementary Table S1 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
Figure S3 from Targeting SALL4 with an HLA Class I–Restricted TCR for Cancer Immunotherapy
Myriam Ben Khelil, Maxime Fredon, Nawfel Adib, Adeline Bouard et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.